George Mo

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Immune Response

Top Venues

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

George Mo, Sang-Yun Lee, David G Coffey, Valentin Voillet, Ilan R Kirsch, Raphaël Gottardo, Kimberly S Smythe, Cecilia C S Yeung, Adam Greenbaum, Damian J Green, David G Maloney, Brian G Till
Long-term Remissions Following CD20-directed Chimeric Antigen Receptor Adoptive T cell Therapy. Blood cancer discovery (2024)
George Mo, Sang-Yun Lee, David G Coffey, Valentin Voillet, Ilan R Kirsch, Raphaël Gottardo, Kimberly S Smythe, Cecilia C S Yeung, Adam Greenbaum, Damian J Green, David G Maloney, Brian G Till
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy. Blood cancer discovery 5 (4) (2024)
George Mo, Sang-Yun Lee, David G Coffey, Valentin Voillet, Ilan R Kirsch, Raphaël Gottardo, Kimberly S Smythe, Cecilia C S Yeung, Adam Greenbaum, Damian J Green, David G Maloney, Brian G Till
Long-term Remissions Following CD20-directed Chimeric Antigen Receptor Adoptive T cell Therapy. Blood cancer discovery (2024)
George Mo, Sang-Yun Lee, David G Coffey, Valentin Voillet, Ilan R Kirsch, Raphaël Gottardo, Kimberly S Smythe, Cecilia C S Yeung, Adam Greenbaum, Damian J Green, David G Maloney, Brian G Till
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy. Blood cancer discovery 5 (4) (2024)
George Mo, Sang-Yun Lee, David G Coffey, Valentin Voillet, Ilan R Kirsch, Raphaël Gottardo, Kimberly S Smythe, Cecilia C S Yeung, Adam Greenbaum, Damian J Green, David G Maloney, Brian G Till
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy. Blood cancer discovery 5 (4) (2024)